Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jonathan Sykes

Otolaryngology Granite Bay, CA Medical Doctor

NPI 1851377493 CMS profile 310493

8975 Camino Del Avion, Granite Bay, CA 95746

Open in the dashboard

General payments

$147,719

146 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$34,149 paid to institutions, not to them · program years 2021–2022

Through program year 2025, Jonathan Sykes of Granite Bay, CA is reported in the CMS Open Payments database as having received $147,719 across 146 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $34,149 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Otolaryngology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $5,280 18
2024 General $32,976 37
2023 General $51,506 35
2022 General $40,864 30
2021 General $3,735 11
2020 General $12,422 3
2019 General $936 12

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jonathan Sykes
  • Otolaryngology median
  • Middle half of Otolaryngology
  • National median

In program year 2025, general payments to Jonathan Sykes were reported at $5,280. Among 6,588 Otolaryngology profiles paid that year, the median was $317 and the middle half received between $125 and $815.

Show as a table
Year Jonathan Sykes Otolaryngology median Middle half National median
2019 $936 $194 $82–$512 $163
2020 $12,422 $118 $42–$280 $114
2021 $3,735 $167 $63–$444 $132
2022 $40,864 $216 $84–$545 $149
2023 $51,506 $235 $93–$588 $160
2024 $32,976 $280 $111–$699 $164
2025 $5,280 $317 $125–$815 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Merz North America, Inc. $121,268 58 payments
  2. Galderma Laboratories, L.P. $14,266 34 payments
  3. Allergan Inc. $6,246 15 payments
  4. Galderma Research & Development, LLC $2,975 1 payment
  5. AbbVie, Inc. $2,786 32 payments
  6. DePuy Synthes Sales Inc. $88 1 payment
  7. Revance Therapeutics, Inc. $26 1 payment
  8. VYNE Pharmaceuticals Inc. $20 1 payment
  9. Solta Medical, a division of Bausch Health US, LLC $18 1 payment
  10. EPI Health, LLC $13 1 payment
  11. Other $12 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $115,799 11 payments
  2. Travel and Lodging $16,597 13 payments
  3. Food and Beverage $8,274 114 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $7,032 6 payments
  5. Education $17 2 payments
Products named General payments · program years 2019–2025
  1. Xeomin Dermatology $12,496 15 payments
  2. BOTOX Facial Aesthetics $4,344 21 payments
  3. Xeomin musculoskeletal $265 1 payment
  4. DYSPORT $211 2 payments
  5. BOTOX COSMETIC $136 2 payments
  6. TRUMATCH $88 1 payment
  7. NATRELLE SALINE-FILLED BREAST IMPLANTS $35 1 payment
  8. ZILXI $20 1 payment
  9. CLEAR+BRILLIANT $18 1 payment
  10. BOTOX Hyperhydrosis $13 1 payment
  11. Other $76 6 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 8 billing codes

Paid by Medicare

$7,856

Medicare's payments for the services billed

Medicare patients

49

Average age 76

Services billed

57

24 women, 25 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 73%
Diabetes 47%
Chronic kidney disease 45%
Heart failure 43%
Atrial fibrillation 41%
Ischemic heart disease 39%
COPD 39%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

3 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Xeomin
  • MERZ NORTH AMERICA, INC. $1,174
$1,174 — —
DYSPORT
  • Galderma Laboratories, L.P. $98
$98 — —
BOTOX
  • AbbVie, Inc. $77
$77 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

146 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Otolaryngology in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record